Search

You searched for "tarsal"

583 results found

United Kingdom and Eire Glaucoma Society (UKEGS) Conference: Last chance for Early Bird tickets!

10 July 2024 | UKEGS, events, conference, congress, early bird, glaucoma, glaucoma uk, diary, Nishani Amerasinghe, Anthony King, Andrew Tatham
The United Kingdom and Eire Glaucoma Society (UKEGS) invites you to its annual conference, hosted by Consultant Ophthalmologist Nishani Amerasinghe, on 9 and 10 October 2024 at the National Oceanography Centre in Southampton.

Q&A: Mr Goel and Mr Loomba on alcohol delamination and phototherapeutic keratectomy (PTK) for the treatment of recurrent corneal erosion syndrome

14 June 2023 | | Cornea / External Eye Disease, ONLINE EXCLUSIVE ARTICLES
Recurrent corneal erosion syndrome is a common, recurrent condition caused by abnormal epithelial adhesion to the underlying basal lamina. Spontaneous breakdown of the corneal epithelium can lead to the sudden onset of ocular pain, blurred vision, tearing and photophobia, typically...

What's trending Apr/May 2023

3 April 2023 | | Ophthalmology
A round-up of the eye-related hot topics that have been trending on social media over the last few weeks. #Cyborgeye #flashlighteye #prostheticeye #BrianStanleyeye Brian Stanley is a California-based engineer, who lost his eye to retinoblastoma when he was six-years-old. A...

In conversation with Robert MacLaren

2 December 2019 | Ophthalmology, Retina / Uvea / Vitreous
Professor Robert MacLaren gave the Keeler Lecture at the Royal College of Ophthalmologists Annual Meeting in May 2019 on gene therapy for retinitis pigmentosa. We caught up with him afterwards to find out more. What are the key messages of...

Ciliatech reports positive clinical results on novel glaucoma implant, CID, in 24-month post-operative follow up

29 March 2023 | glaucoma
Chavanod (near Annecy), France, March 29, 2023 - Ciliatech, an ophthalmology medtech company developing a new class of implant to treat glaucoma durably, announced the positive results of a 24-month post-operative follow-up on a clinical trial of CID, its first generation Cilio-scleral Inter-positioning Device.

Triamcinolone (TA) deposits following subcutaneous injection to treat chalazion

2 August 2022 | | Ophthalmology, Oculoplastics
Chalazia are chronic lipogranulomatous inflammations of the eyelid secondary to a blocked meibomian gland. Whilst most resolve spontaneously, certain chalazia warrant treatment. Options include incision and curettage (I&C), lesion excision, intralesional steroid injections, and botox injections [1]. I&C is usually...

Oct/Nov 2019 Quiz

1 October 2019 | Ophthalmology
History A 62-year-old female patient was referred for rapid growth of a left periorbital soft tissue lesion with proptosis. Her past medical history included: hypertension, hyperlipidaemia and bipolar disorder. On examination: vision in the affected eye was hand movements, right...

Iris chafing from displaced single-piece acrylic IOL

4 August 2021 | | Ophthalmology, Cataract and Refractive, Imaging
A 74-year-old man had persistent 3+ cell one month following left eye cataract extraction, complicated by anterior capsular rent and zonular dialysis at 7 o’clock, with single-piece acrylic intraocular lens implantation (IOL) in the capsular bag. Figure 1: Haptic-like transillumination...

External dacryocystorhinostomy in the management of childhood epiphora

1 December 2014 | | Paediatric Ophthalmology / Strabismus
Congenital nasolacrimal duct obstruction is thought to be caused by a membranous obstruction at the distal end of the nasolacrimal duct (NLD). Rarely, associated midline deformities in soft tissue and bony structures of the face are present in patients with...

On the wrong track

1 June 2015 | | Cataract and Refractive, Imaging, Ophthalmology, Retina / Uvea / Vitreous
A 65-year-old very high myope lady presented with sudden blurred vision down to count fingers to her right eye after a short and sharp pain. She also described seeing a black swirly line and as all these symptoms were exactly...

Emerging therapies for geographic atrophy: complement inhibitors show potential to slow progression and preserve RPE and photoreceptor integrity

5 June 2023 |
Geographic atrophy (GA) is an advanced form of age-related macular degeneration (AMD) characterised by progressive, irreversible loss of the retinal pigment epithelium (RPE) and photoreceptors and is estimated to account for approximately 10% of AMD-related blindness [1-4]. The Age-Related Eye...

Addressing medical risk factors for diabetes and understanding the new systemic treatments

1 February 2014 |
As global diabetes figures continue to rise, the importance of reducing the burden of macrovascular and microvascular complications of diabetes has never been so great. By 2025 it is estimated that five million people in the UK will have diabetes...